Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Microbiology|June 1, 2007
Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samplesM Chernesky, D Jang, E Portillo, et al.
The European Respiratory Journal|August 24, 2010
Association of airflow limitation with trauma exposure and post-traumatic stress disorderC Spitzer, B Koch, H J Grabe, et al.
The European Respiratory Journal|July 2, 2011
Airflow limitation, lung volumes and systemic inflammation in a general populationS Gläser, T Ittermann, B Koch, et al.
Pneumologie (Stuttgart, Germany)|July 15, 2020
[Current Aspects of Definition and Diagnosis of Pulmonary Hypertension]T J Lange, M Borst, R Ewert, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Risk stratification and follow-up assessment of patients with pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016]H H Leuchte, H Ten Freyhaus, H Gall, et al.
Pneumologie (Stuttgart, Germany)|February 12, 2021
[Differential Diagnosis of Pulmonary Hypertension Using the Example of Collagenosis-associated PAH in the Context of Chronic Lung and Left Heart Disease]H H Leuchte, M Halank, M Held, et al.
Pneumologie (Stuttgart, Germany)|May 16, 2017
[Weaning Unit of the University Medicine Greifswald - Institutional Structure and Weaning Results from Prolonged Ventilation over 10 Years]A Müller-Heinrich, C Warnke, A Heine, et al.
The European Respiratory Journal|March 3, 2009
Long-term outcome with intravenous iloprost in pulmonary arterial hypertensionM M Hoeper, H Gall, H J Seyfarth, et al.
Pneumologie (Stuttgart, Germany)|December 19, 2012
[The Study of Health in Pomerania (SHIP) reference values for cardiopulmonary exercise testing]S Gläser, T Ittermann, C Schäper, et al.
Pneumologie (Stuttgart, Germany)|March 10, 2015
[Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension]H H Leuchte, J Behr, R Ewert, et al.
Pageof 10